NuVasive have announced it has entered into a strategic partnership with Biedermann Technologies, a company that holds a broad and extensive patent and technology portfolio in the fields of spinal and extremity surgery, based in Donaueschingen, Germany.
Biedermann Technologies works within many medical device industries and holds one of the most comprehensive patent portfolios in the field of spinal surgery. Within the terms of the license and services agreement, Biedermann Technologies has granted NuVasive licenses to intellectual property relating to its spinal technology portfolio.
Specifically, certain Biedermann Technologies’ proprietary screw innovations will be integrated into the NuVasive Reline portfolio, which, according to a company press release, offers surgeons a solution to treat complex spinal pathologies in both the adult and paediatric populations for open, as well as minimally invasive surgery, with customised screw placement and the ability to facilitate various corrective maneuvers based on the clinical needs of the patient. NuVasive’s Reline system is the only technology on the market to offer a single tulip that accepts three posterior fixation rods of different diameters and is integrated into its proprietary Integrated Global Alignment (iGA) platform designed to achieve global alignment across spinal procedures.
This combination of Biedermann Technologies’ propriety screw technology and NuVasive’s Reline system is expected to be commercially available to surgeons in the first half of 2019.
Biedermann Technologies will also provide services to NuVasive in connection with the development of its next-generation Reline complex spine system to support three foundational clinical pillars: surgical efficiency, operative reliability and procedural versatility.
“Partnering with Biedermann Technologies—a highly innovative medical device design powerhouse—coupled with NuVasive’s best-in-class engineering teams and innovation prowess—will accelerate the development and time-to-market to put the most advanced posterior fixation solutions in the hands of our surgeon partners,” says Matt Link, executive vice president for Strategy, Technology and Corporate Development at NuVasive. “This partnership will help create better, more reproducible clinical outcomes in some of the hardest to treat spine pathologies, and further demonstrates our commitment to R&D investments to create the future of leading complex spinal innovation.”
“Significant challenges demand smart collaborations,” comments Lutz Biedermann, founder and president of Biedermann Technologies. “And reconstructive spine surgery of complex deformities and instabilities of all age groups is still such a significant clinical challenge. With this in mind, I welcome the opportunity to work with NuVasive’s very talented and skilled organisation to offer clinically meaningful solutions to the global spine community.”
NuVasive is showcasing the Reline system featuring Biedermann Technologies’ innovations at the Scoliosis Research Society 2018 Annual Meeting (SRS; 10–13 October, Bologna, Italy).
